Home
Charts
Search
Watchlist
Products
All IPOs
₹85 - 85
Invicta Diagnostic Ltd
HealthcareIPOSME
₹85 - 85
We are a diagnostic chain in Mumbai Metropolitan Region ("MMR") offering radiology and pathology solutions. We offer radiology and pathology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers under the brand name "PC Diagnostics" through our operational network, which consists of 7 diagnostic centres and 1 centralised laboratory across MMR in the state of Maharashtra either directly or through our subsidiaries.
Lot1,600Min Invest₹2,72,000Face Value₹10Issue Size₹28 CrFresh Issue₹28 CrListing Price₹100CMP₹68
Timeline
1 Dec
Bidding opens
3 Dec
Bidding closes
4 Dec
Allotment
5 Dec
Refund & demat credit
8 Dec
Listing
Subscription
Subscription opens once dates are announced
Reports
Offer Details
Terms
Issue Size₹28 Cr0.33 Cr shares
Fresh Issue₹28 Cr
Face Value₹10
Lot Size1,600 shares
ReservationQIB 50% · NII 15% · RETAIL 35%
Application Sizes
Retail₹2,72,0001-1 lots
sNII₹2,72,000from 2 lots
bNII₹10,88,000from 8 lots
Managers & Registrar
Lead ManagerSocradamus Capital Pvt Ltd
RegistrarBigshare Services Pvt Ltd
Ownership & Proceeds
Shareholding
CategoryPre IPOPost IPOPromoter Group90.51%66.7%Public9.49%33.3%
Objects of the Issue
- Funding capital exp for purchase of medical equipment towards establishment of new diagnostic centers in
- General corporate purposes
Financials
Profit & Loss
| Financial Year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| RevenueCr | 7 | 8 | 30 | 32 |
| Operating ProfitCr | 3 | 3 | 9 | 10 |
| OPM% | 43.4 | 42.6 | 30.6 | 30.2 |
| PBTCr | 2 | 3 | 7 | 7 |
| PATCr | 2 | 3 | 5 | 5 |
| EPS | - | 3 | 6 | 5 |
Balance Sheet
| Financial Year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Equity CapitalCr | - | 0 | 8 | 13 |
| ReservesCr | - | 12 | 5 | 37 |
| BorrowingsCr | - | 2 | 4 | 4 |
| Total AssetsCr | - | 16 | 21 | 60 |
Cash Flow
| Financial Year | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Operating Cash FlowCr | - | 4 | 7 | 3 |
| Investing Cash FlowCr | - | -10 | -5 | -14 |
| Financing Cash FlowCr | - | 7 | -1 | 31 |
| Net Cash FlowCr | - | 1 | 1 | 20 |
Strengths & Risks
Strengths · as stated in the DRHP
- Expanding presence in Mumbai Metropolitan Region ("MMR") specifically in radiology sector.
- Diagnostics provider that offers one-stop solution at affordable price.
- Technical capability and technology with IT infrastructure.
- Dedicated management team with significant industry experience.
- Implementation of Hub and Spoke Model.
Strategies · as stated in the DRHP
- Expanding geographic footprint across the Maharashtra.
- Deepen footprint in our core markets and Physician Outreach.
- Branding and Advertising.
- Supplement Organic Growth with Acquisitions.
Risks · as stated in the DRHP
- Its business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.
- Any interruptions at its flagship centre and other diagnostic centres may affect the company ability to process diagnostic tests, which in turn may adversely affect its business, results of operations and financial condition.
- Concentrated emphasis on radiology services also exposes it to substantial risks that could adversely impact its operations, financial performance, and long-term growth prospects.
- The company operations are concentrated in Mumbai Metropolitan Region ("MMR"), and any loss of business in such region could have an adverse effect on its business, results of operations and financial condition.
- Its ability to remain competitive may be adversely affected by technological advancements, innovations in diagnostic testing and its ability to access such technology.
- The company operates in a highly competitive business environment, and its inability to compete effectively could have an adverse effect on the company business, results of operations and financial condition.